Healthcare Provider Empathy and Clinical Outcomes in Diabetes

Study examines the relationship between physicians' empathy and reducing complications from diabetes

By Catherine Ulbricht, PharmD, MBA[c]

Printer Friendly PagePrinter Friendly Page

Reference

Canale SD, Louis DZ, Maio V, et al. The relationship between physician empathy and disease complications: an empirical study of primary care physicians and their diabetic patients in Parma, Italy. Acad Med. 2012;87(9):1243-1249.
 

Design

A retrospective correlational study
 

Participants

20,961 participants from a population of 284,298 adults in Parma, Italy, whom were enrolled with 1 of 242 primary care physicians in 2009. Participants were aged 18 years or older and diagnosed with diabetes mellitus, type 1 or 2, either by ICD-9-CM code on hospitalization or having a prescription for a diabetes medication. Sixty-one percent of the participants were older than 65 years of age, and 51% of the participants were male.
 

Study Parameters Assessed

The association between a Jefferson Scale of Empathy (JSE) score and clinical outcomes for patients with diabetes mellitus
 

Primary Outcome Measures

The JSE consisted of 20 items answered on a 7-point scale with 1 meaning “strongly disagree” and 7 meaning “strongly agree.” Points measured included perspective-taking, compassionate care, and walking in the patient’s shoes. Clinical outcomes focused on acute metabolic complications including hyperosmolar state, diabetic ketoacidosis, and coma.
 

Key Findings

Based on empathy scores, physicians were classified into three groups whose mean JSE scores were significantly different (P<0.001): high (n=81, JES score 119.4±5.4), moderate (n=84, 105.1±4.3), and low (n=77, 85.2±15.4). Physicians with high empathy scores had significantly fewer patients with acute metabolic complications (4.0/1,000 patients) compared with moderate (7.1/1,000 patients; z=2.51, P<0.01) and low empathy scores (6.5/1,000 patients) (z=2.04, P<0.05). Switching from a low to high JES-scoring physician reduced the odds of metabolic complications in diabetic patients by 40% (OR 0.59, [95% CI: 0.37–0.95]). Being older (aged ≥69 years) increased the odds of metabolic complications in patients by 70% (OR 1.70, [95% CI: 1.2–1.4]).
 

Practice Implications

Physician empathy in this study was shown to help in reducing serious metabolic complications from diabetes. In an earlier study published in 2011, Hojat et al reported that “patients of physicians with high empathy scores were significantly more likely to have good control of hemoglobin A1c (56%) than were patients of physicians with low empathy scores (40%, P<0.001).”1
 
These improvements in outcomes may have been associated with increased patient compliance. In other research, empathy and patient-centered communication have been shown to be associated with improved clinician-to-patient relationships, patient satisfaction, and compliance.6–9 It is likely that empathy from other members of the multidisciplinary healthcare team is helpful as well. Therefore, practitioners other than primary care MDs, such as PharmDs, RNs, and RDs, may play a vital role in patient care and satisfaction. Including complementary and alternative medicine (CAM) providers such as NDs in the patient care team may add even more value, thus further improving outcomes.
 
Physicians with high empathy scores had significantly fewer patients with acute metabolic complications.
 
Some CAM therapies and dietary supplements and the additional attention case managers bring may also improve outcomes in diabetes or reduce complications associated with it. Alpha-lipoic acid and konjac glucomannan have strong scientific evidence for efficacy in diabetes.2 Beta-glucan, fenugreek (Trigonella foenum-graecum; DM-2), ivy gourd (Coccinia indica), guar gum, Gymnema (Gymnema sylvestre), and whey protein have good scientific evidence for efficacy in diabetes.2 Many other herbs and supplements, such as barley (Hordeum vulgare), beet (Beta vulgaris), chromium, ginseng (Panax spp), psyllium (Plantago ovata, Plantago ispaghula), and seaweed may affect glucose levels when taken alone or concurrently with other supplements.2 However, just like prescription drugs, some integrative therapies may not be safe in certain patient populations; therefore, appropriate monitoring parameters and screening for interactions/depletions is important. However, just like prescription drugs, some integrative therapies may not be safe in certain patient populations, therefore, appropriate monitoring parameters and screening for interactions/depletions is important.
 
Apart from CAM therapies potentially being effective prevention or treatment options for many disease states, CAM practitioners work to empower patients and encourage them to take responsibility for their own health. These practitioners’ treatment recommendations often take into consideration patient beliefs and preferences. CAM practitioners also have been shown to be more open-minded,3,4 spend more time with their patients,3,4 offer choices,3 share their knowledge and vision with patients,3 and form stronger bonds with their patients.4 Other research shows that CAM practitioners’ increased time spent with patients led to more general problems being diagnosed than in mainstream practitioners’ offices.5
 
Preliminary research has shown naturopathic care to result in improved outcomes in patients with type 2 diabetes. A small prospective observational pilot study (N=12) published in 2011 investigated changes in outcome measures in patients with type 2 diabetes after a 3-month dietary education program delivered in naturopathic primary care.10 It was reported that hemoglobin A1c improved significantly (P=0.02), adherence to healthy eating increased (P=0.05), and measures of physical activity, self-efficacy, and self-management improved significantly. In another prospective study published in 2012, 40 patients with inadequately controlled type 2 diabetes recruited from a large integrated healthcare system received on average 3.9 adjunctive naturopathic care (ANC) visits during the year of the study.11 At 6 months, significant improvements were noted in glucose testing (P=0.001), mood (P=0.001), self-efficacy (P=0.0001), and motivation to change lifestyle (P=0.003), all of which persisted at 12 months (P<0.005). At 6 months, mean hemoglobin A1c was also reported to have decreased by 0.90% (P=0.02) in patients receiving ANC; however, at 12 months, reductions were not statistically significant (P=0.14).
 
The following question has been raised: Can CAM practitioners be successful in managing or treating diabetes given their emphasis on overall mind-body wellness and the empathy upon which this approach depends, the specific therapies they recommend, or a combination of both? While research has been conducted on clinical algorithms for nutritional and botanical medicines in the treatment of type 2 diabetes,12 similar models specifically involving the use of empathy in naturopathic treatment of diabetes are lacking. It is generally accepted that a healthy lifestyle and diet are central to diabetes management and treatment, but in many cases this is not adequately communicated to patients or it is challenging for patients to comply. Thus it has been suggested that empathy may play a role in improving compliance and outcomes in patients with diabetes.
 
This information should stimulate a collaborative effort among practitioners to have empathy and encourage increased patient interaction with the goal of improving healthcare outcomes in diabetes and other indications.

About the Author

Catherine (Kate) Ulbricht, PharmD, MBA[c] is co-founder of Natural Standard Research Collaboration. She serves as Senior Attending Pharmacist, Massachusetts General Hospital and Adjunct/Assistant Clinical Professor at multiple universities. She serves on the Editorial Board of Harvard Health Publications, Journal of the American Nutraceutical Association, Journal of Integrative Cancer Medicine, Pharmacy Practice News and many others. She is Editor-in-Chief of the Journal of Dietary Supplements. Her background includes experience in the areas of quality improvement, healthcare informatics, regulatory affairs, clinical trial protocol analysis and drug therapy decision-support. She has also been trained in physical therapy and chiropractic care. For more information on the natural Standard Research Collaboration visit www.naturalstandard.com.

References

  1.  Hojat M, Louis DZ, Markham FW, Wender R, Rabinowitz C, Gonnella JS. Physicians' empathy and clinical outcomes for diabetic patients. Acad Med. 2011;86(3):359-364.
  2.  Natural Standard: The Authority on Integrative Medicine. Available at www.naturalstandard.com. Accessed 10/18/12.
  3. Maizes, V, Rakel, D, Niemiec, C. Integrative Medicine and Patient-Centered Care. EXPLORE. 2009;5(5): 277-228.
  4.  Boon H, Stewart M, Kennard M, Guidmond J. Comparing patient-practitioner interactions. Canadian Family Physician. 2003;49:1481-1487
  5.  Bertisch SM, Wee CC, Phillips RS, McCarthy EP. Alternative mind-body therapies used by adults with medical conditions. J Psychosom Res. 2009;66(6):511-519.
  6.  Pinto RZ, Ferreira ML, Oliveira VC, et al. Patient-centered communication is associated with positive therapeutic alliance: a systematic review. J Physiother. 2012;58(2):77-87.
  7.  Mercer SW, Reynolds WJ. Empathy and quality of care. Br J Gen Pract. 2002;52 Suppl:S9-12.
  8.  Kim SS, Kaplowitz S, Johnston MV. The effects of physician empathy on patient satisfaction and compliance. Eval Health Prof. 2004;27(3):237-251.
  9.  Neumann M, Scheffer C, Tauschel D, Lutz G, Wirtz M, Edelhäuser F. Physician empathy: definition, outcome-relevance and its measurement in patient care and medical education. GMS Z Med Ausbild. 2012;29(1):Doc11.
  10.  Oberg EB, Bradley RD, Allen J, McCrory MA. CAM: naturopathic dietary interventions for patients with type 2 diabetes. Complement Ther Clin Pract. 2011;17(3):157-161.
  11.  Bradley R, Sherman KJ, Catz S, et al. Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year. BMC Complement Altern Med. 2012;12:44.
  12.  Bradley R, Oberg EB, Calabrese C, Standish LJ. Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern Complement Med. 2007;13(1):159-175.